Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 8, Number 7—July 2002

Research

First Human Isolate of Hantavirus (Andes virus) in the Americas

Hector Galeno*, Judith Mora*, Eliecer Villagra*, Jorge Fernandez*, Jury Hernandez†, Gregory J. Mertz‡, and Eugenio Ramirez*Comments to Author 
Author affiliations: *Public Health Institute of Chile, Santiago, Chile; †Los Angeles Hospital, Santiago, Chile; ‡University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA;

Main Article

Figure 1

Immunofluorescence assay (IFA) of Vero E6 cells infected with Chilean hantavirus CHI-7913 isolate. A, IFA with seropositive human sera from a Chilean HPS patient; arrow shows infected Vero E6 cells expressing hantavirus antigens. B, IFA with seronegative human sera from uninfected control; arrow shows the negative IFA of Vero E6 cells infected with the CHI-7913 isolate.

Figure 1. Immunofluorescence assay (IFA) of Vero E6 cells infected with Chilean hantavirus CHI-7913 isolate. A, IFA with seropositive human sera from a Chilean HPS patient; arrow shows infected Vero E6 cells expressing hantavirus antigens. B, IFA with seronegative human sera from uninfected control; arrow shows the negative IFA of Vero E6 cells infected with the CHI-7913 isolate.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO